Literature DB >> 1315133

Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector.

S Kit1, H Otsuka, M Kit.   

Abstract

Recombinant DNA techniques were used to insert foreign genes into bovine herpesvirus-1 [infectious bovine rhinotracheitis virus (IBRV)] vectors which were attenuated by deletion and/or insertion mutations in the IBRV thymidine kinase (tk) gene. In one recombinant, the regulatory and coding sequences of the late pseudorabies virus (PRV) glycoprotein gIII gene, were inserted into the early IBRV tk gene. This recombinant efficiently expressed the PRV gIII gene indicating that immediate early IBRV proteins were competent to transactivate the late PRV gIII gene. IBRV vector viruses were also prepared in which the coding sequences of the early PRV tk gene, the late PRV gIII gene, and the E. coli beta-galactosidase gene were ligated to the late IBRV gIII promoter. Genotypes and phenotypes of the recombinant viruses were verified by restriction endonuclease and molecular hybridization experiments, thymidine plaque autoradiography, beta-gal plaque assays, and by immunoprecipitation experiments on extracts from 3H-mannose-labelled cells. The recombinant IBRV expressing beta-gal from the IBRV gIII promoter has been useful as an intermediate in the construction of IBRV vectors harboring foreign DNA sequences. The infectivity of the IBRV recombinant that expressed PRV gIII from the IBRV gIII promoter, was neutralized by polyclonal PRV antisera and by monoclonal antibodies to PRV gIII. The PRV gIII glycoprotein synthesized by the preceding recombinant has been used to coat microtiter test plate wells in a PRV gIII differential diagnostic test kit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315133     DOI: 10.1007/bf01314621

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units.

Authors:  U V Wirth; B Vogt; M Schwyzer
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.

Authors:  M Kit; S Kit; S P Little; R D Di Marchi; C Gale
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

3.  Structure of vaccinia virus early promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

4.  Beta-galactosidase gene fusions for analyzing gene expression in escherichia coli and yeast.

Authors:  M J Casadaban; A Martinez-Arias; S K Shapira; J Chou
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization.

Authors:  A K Robbins; J P Ryan; M E Whealy; L W Enquist
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  Bovine naturally cytolytic cell activation against bovine herpes virus type 1-infected cells does not require late viral glycoproteins.

Authors:  C G Cook; G J Letchworth; G A Splitter
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

7.  Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes.

Authors:  G Inchauspe; J M Ostrove
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

8.  Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1.

Authors:  I Rauh; F Weiland; F Fehler; G M Keil; T C Mettenleiter
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.

Authors:  M Kit; S Kit
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

10.  A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  M E Whealy; K Baumeister; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

View more
  10 in total

1.  Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the thymidine kinase and UL24 genes of herpes simplex virus type 1.

Authors:  Y Shimojima; H K Jang; M Ono; K Maeda; Y Tohya; T Mikami
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1.

Authors:  G Kühnle; A Heinze; J Schmitt; K Giesow; G Taylor; I Morrison; F A Rijsewijk; J T van Oirschot; G M Keil
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Identification and nucleotide sequence of the thymidine kinase gene of canine herpesvirus.

Authors:  X Xuan; K Maeda; Y Tohya; T Mikami; H Otsuka
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

Review 4.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

5.  Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD, and gE.

Authors:  H Otsuka; X Xuan
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 6.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

Review 7.  Adenoviruses as vectors for delivering vaccines to mucosal surfaces.

Authors:  L A Babiuk; S K Tikoo
Journal:  J Biotechnol       Date:  2000-09-29       Impact factor: 3.307

8.  Development of an Indirect ELISA Based on Spike Protein to Detect Antibodies against Feline Coronavirus.

Authors:  Bo Dong; Gaoqiang Zhang; Xiaodong Zhang; Xufei Chen; Meiling Zhang; Linglin Li; Weiming Lin
Journal:  Viruses       Date:  2021-12-13       Impact factor: 5.048

9.  Development and Primary Application of an Indirect ELISA Based on Rep Protein to Analyze Antibodies against Porcine Cocirvirus-like Virus (PCLV).

Authors:  Zheng Chen; Xifeng Hu; Xiangdong Wu; Yu Li; Zhen Ding; Qinghua Zeng; Tong Wan; Jingyi Yin; Huansheng Wu
Journal:  Viruses       Date:  2022-06-27       Impact factor: 5.818

Review 10.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.